Literature DB >> 1648907

An endothelin receptor (ETA) antagonist isolated from Streptomyces misakiensis.

M Ihara1, T Fukuroda, T Saeki, M Nishikibe, K Kojiri, H Suda, M Yano.   

Abstract

A competitive endothelin (ET) antagonist, BE-18257B, was isolated from the fermentation products of Streptomyces misakiensis. It is a novel cyclic pentapeptide, cyclo(-D-Glu-L-Ala-allo-D-Ile-L-Leu-D-Trp-), and binds to ETA receptors (ET-1 selective) in cardiovascular tissues, but not to ETB receptors (equally sensitive to isopeptides of ET family) in kidney, adrenal gland and cerebellum tissues. BE-18257B also antagonizes ET-1-induced vasoconstriction in rabbit iliac artery and pressor action in rats. Thus it is a selective ETA antagonist and should provide a valuable tool for elucidation of the pharmacological and pathophysiological roles of ET-1.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1648907     DOI: 10.1016/0006-291x(91)91789-f

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  15 in total

Review 1.  Endothelial regulation of vascular tone.

Authors:  P Vallance
Journal:  Postgrad Med J       Date:  1992-09       Impact factor: 2.401

2.  Development of occlusive neointimal lesions in distal pulmonary arteries of endothelin B receptor-deficient rats: a new model of severe pulmonary arterial hypertension.

Authors:  D Dunbar Ivy; Ivan F McMurtry; Kelley Colvin; Masatoshi Imamura; Masahiko Oka; Dong-Seok Lee; Sarah Gebb; Peter Lloyd Jones
Journal:  Circulation       Date:  2005-05-31       Impact factor: 29.690

3.  Endothelin (16-21): biphasic effect and no desensitization on the guinea-pig isolated ileum.

Authors:  N Miasiro; C R Nakaie; A C Paiva
Journal:  Br J Pharmacol       Date:  1993-05       Impact factor: 8.739

Review 4.  Endothelins. A potential target for pharmacological intervention in diseases of the elderly.

Authors:  H Lévesque; N Moore; N Cailleux; V Richard; C Thuillez; H Courtois
Journal:  Drugs Aging       Date:  1994-03       Impact factor: 3.923

5.  Mediation via different receptors of the vasoconstrictor effects of endothelins and sarafotoxins in the systemic circulation and renal vasculature of the anaesthetized rat.

Authors:  J P Cristol; T D Warner; C Thiemermann; J R Vane
Journal:  Br J Pharmacol       Date:  1993-03       Impact factor: 8.739

6.  Incomplete inhibition of the pressor effects of endothelin-1 and related peptides in the anaesthetized rat with BQ-123 provides evidence for more than one vasoconstrictor receptor.

Authors:  L McMurdo; R Corder; C Thiemermann; J R Vane
Journal:  Br J Pharmacol       Date:  1993-02       Impact factor: 8.739

7.  Enhancement by endothelin-1 of microvascular permeability via the activation of ETA receptors.

Authors:  J G Filep; M G Sirois; E Földes-Filep; A Rousseau; G E Plante; A Fournier; M Yano; P Sirois
Journal:  Br J Pharmacol       Date:  1993-07       Impact factor: 8.739

8.  Mediation of endothelin-1-induced inhibition of platelet aggregation via the ETB receptor.

Authors:  L McMurdo; P S Lidbury; C Thiemermann; J R Vane
Journal:  Br J Pharmacol       Date:  1993-06       Impact factor: 8.739

9.  Endothelin ETA and ETB receptors mediate vascular smooth muscle contraction.

Authors:  M J Sumner; T R Cannon; J W Mundin; D G White; I S Watts
Journal:  Br J Pharmacol       Date:  1992-11       Impact factor: 8.739

10.  Human big-endothelin-1 and endothelin-1 release prostacyclin via the activation of ET1 receptors in the rat perfused lung.

Authors:  P D'Orléans-Juste; S Télémaque; A Claing; M Ihara; M Yano
Journal:  Br J Pharmacol       Date:  1992-04       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.